echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Dentons Biochemicals half-year profit and profit to make 100 million

    Dentons Biochemicals half-year profit and profit to make 100 million

    • Last Update: 2020-07-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dentons Biochemical Technology announced that shareholders should have a profit of RMB 104 million, or 4.5 cents per share, and no dividend stake, while revenue rose 12.7% to RMB3.828 billion for the period ended June 2010the company recorded a loss of $90.53 million for the same period in 2009Dentons Biochemical Technology announced that shareholders should account for a profit of 104 million yuan, or 4.5 cents per share, and no dividend stake, while revenue rose 12.7 percent to 3.828 billion yuan for the period ended June 2010the company recorded a loss of $90.53 million for the same period in 2009(Name) 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.